PUXIN LTD-ADR (NEW) Stock Fundamental Analysis

NYSE:NEW • US74704P4054

1.36
+0.08 (+6.25%)
Last: May 3, 2022, 08:22 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

Taking everything into account, NEW scores 1 out of 10 in our fundamental rating. NEW was compared to 75 industry peers in the Diversified Consumer Services industry. Both the profitability and financial health of NEW have multiple concerns. NEW has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year NEW was profitable.
NEW Yearly Net Income VS EBIT VS OCF VS FCFNEW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 0 -200M -400M -600M -800M

1.2 Ratios

Industry RankSector Rank
ROA 1.02%
ROE 10.46%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NEW Yearly ROA, ROE, ROICNEW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 0 100 -100 200

1.3 Margins

Industry RankSector Rank
OM -5.97%
PM (TTM) 1.73%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NEW Yearly Profit, Operating, Gross MarginsNEW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. Health

2.1 Basic Checks

  • NEW has more shares outstanding than it did 1 year ago.
  • NEW has a worse debt/assets ratio than last year.
NEW Yearly Shares OutstandingNEW Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 200M 400M 600M 800M
NEW Yearly Total Debt VS Total AssetsNEW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 1B 2B 3B 4B

2.2 Solvency

  • NEW has an Altman-Z score of -0.29. This is a bad value and indicates that NEW is not financially healthy and even has some risk of bankruptcy.
  • NEW has a Debt/Equity ratio of 1.43. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.43
Debt/FCF N/A
Altman-Z -0.29
ROIC/WACCN/A
WACCN/A
NEW Yearly LT Debt VS Equity VS FCFNEW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 0 200M -200M 400M 600M

2.3 Liquidity

  • NEW has a Current Ratio of 0.39. This is a bad value and indicates that NEW is not financially healthy enough and could expect problems in meeting its short term obligations.
  • A Quick Ratio of 0.38 indicates that NEW may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.39
Quick Ratio 0.38
NEW Yearly Current Assets VS Current LiabilitesNEW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • NEW shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 113.26%, which is quite impressive.
  • NEW shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -12.35%.
  • NEW shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 60.35% yearly.
EPS 1Y (TTM)113.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%186.7%
Revenue 1Y (TTM)-12.35%
Revenue growth 3Y31.31%
Revenue growth 5Y60.35%
Sales Q2Q%-8.59%

3.2 Future

  • The Earnings Per Share is expected to decrease by -5.61% on average over the next years.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-91.96%
EPS Next 2Y-51.74%
EPS Next 3Y-29.84%
EPS Next 5Y-5.61%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NEW Yearly Revenue VS EstimatesNEW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 1B 2B 3B
NEW Yearly EPS VS EstimatesNEW Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 136.00, which means the current valuation is very expensive for NEW.
  • Compared to an average S&P500 Price/Earnings ratio of 27.09, NEW is valued quite expensively.
  • A Price/Forward Earnings ratio of 1.50 indicates a rather cheap valuation of NEW.
  • The average S&P500 Price/Forward Earnings ratio is at 27.98. NEW is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 136
Fwd PE 1.5
NEW Price Earnings VS Forward Price EarningsNEW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -24.8
NEW Per share dataNEW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

  • NEW's earnings are expected to decrease with -29.84% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-51.74%
EPS Next 3Y-29.84%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for NEW!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

PUXIN LTD-ADR

NYSE:NEW (5/3/2022, 8:22:04 PM)

1.36

+0.08 (+6.25%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)03-14
Earnings (Next)05-23
Inst Owners0.32%
Inst Owner Change-90.6%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap118.95M
Revenue(TTM)2.84B
Net Income(TTM)49.10M
Analysts84
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 136
Fwd PE 1.5
P/S 0.28
P/FCF N/A
P/OCF N/A
P/B 1.72
P/tB N/A
EV/EBITDA -24.8
EPS(TTM)0.01
EY0.74%
EPS(NY)0.91
Fwd EY66.58%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS4.78
BVpS0.79
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 1.02%
ROE 10.46%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -5.97%
PM (TTM) 1.73%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 1.43
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.39
Quick Ratio 0.38
Altman-Z -0.29
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)113.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%186.7%
EPS Next Y-91.96%
EPS Next 2Y-51.74%
EPS Next 3Y-29.84%
EPS Next 5Y-5.61%
Revenue 1Y (TTM)-12.35%
Revenue growth 3Y31.31%
Revenue growth 5Y60.35%
Sales Q2Q%-8.59%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

PUXIN LTD-ADR / NEW FAQ

What is the fundamental rating for NEW stock?

ChartMill assigns a fundamental rating of 2 / 10 to NEW.


What is the valuation status of PUXIN LTD-ADR (NEW) stock?

ChartMill assigns a valuation rating of 3 / 10 to PUXIN LTD-ADR (NEW). This can be considered as Overvalued.


How profitable is PUXIN LTD-ADR (NEW) stock?

PUXIN LTD-ADR (NEW) has a profitability rating of 3 / 10.


What is the earnings growth outlook for PUXIN LTD-ADR?

The Earnings per Share (EPS) of PUXIN LTD-ADR (NEW) is expected to decline by -91.96% in the next year.